SGRY Annual FCF
$205.00 M
+$126.80 M+162.15%
31 December 2023
Summary:
As of January 21, 2025, SGRY annual free cash flow is $205.00 million, with the most recent change of +$126.80 million (+162.15%) on December 31, 2023. During the last 3 years, it has risen by +$1.00 million (+0.49%). SGRY annual FCF is now at all-time high.SGRY Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SGRY Quarterly FCF
$45.00 M
-$10.90 M-19.50%
30 September 2024
Summary:
As of January 21, 2025, SGRY quarterly free cash flow is $45.00 million, with the most recent change of -$10.90 million (-19.50%) on September 30, 2024. Over the past year, it has dropped by -$10.90 million (-19.50%). SGRY quarterly FCF is now -74.11% below its all-time high of $173.80 million, reached on June 30, 2020.SGRY Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SGRY TTM FCF
$163.40 M
-$40.70 M-19.94%
30 September 2024
Summary:
As of January 21, 2025, SGRY TTM free cash flow is $163.40 million, with the most recent change of -$40.70 million (-19.94%) on September 30, 2024. Over the past year, it has dropped by -$40.70 million (-19.94%). SGRY TTM FCF is now -29.48% below its all-time high of $231.70 million, reached on June 30, 2020.SGRY TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SGRY Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +162.2% | -19.5% | -19.9% |
| 3 y3 years | +0.5% | +703.6% | +453.9% |
| 5 y5 years | +95.6% | +703.6% | +453.9% |
SGRY Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +594.9% | -47.5% | +390.3% | -20.3% | +453.9% |
| 5 y | 5-year | at high | +594.9% | -74.1% | +390.3% | -29.5% | +823.2% |
| alltime | all time | at high | +1342.3% | -74.1% | +390.3% | -29.5% | +3931.6% |
Surgery Partners Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $45.00 M(-19.5%) | $163.40 M(-19.9%) |
| June 2024 | - | $55.90 M(+183.8%) | $204.10 M(+17.0%) |
| Mar 2024 | - | $19.70 M(-54.0%) | $174.50 M(-14.9%) |
| Dec 2023 | $205.00 M(+162.1%) | $42.80 M(-50.1%) | $205.00 M(+39.7%) |
| Sept 2023 | - | $85.70 M(+225.9%) | $146.70 M(+99.9%) |
| June 2023 | - | $26.30 M(-47.6%) | $73.40 M(+9.9%) |
| Mar 2023 | - | $50.20 M(-423.9%) | $66.80 M(-14.6%) |
| Dec 2022 | $78.20 M(+165.1%) | -$15.50 M(-225.0%) | $78.20 M(-21.2%) |
| Sept 2022 | - | $12.40 M(-37.1%) | $99.30 M(+15.1%) |
| June 2022 | - | $19.70 M(-68.0%) | $86.30 M(+55.8%) |
| Mar 2022 | - | $61.60 M(+1000.0%) | $55.40 M(+87.8%) |
| Dec 2021 | $29.50 M(-85.5%) | $5.60 M(-1033.3%) | $29.50 M(+66.7%) |
| Sept 2021 | - | -$600.00 K(-94.6%) | $17.70 M(-52.5%) |
| June 2021 | - | -$11.20 M(-131.4%) | $37.30 M(-83.2%) |
| Mar 2021 | - | $35.70 M(-675.8%) | $222.30 M(+9.0%) |
| Dec 2020 | $204.00 M(+264.9%) | -$6.20 M(-132.6%) | $204.00 M(-3.9%) |
| Sept 2020 | - | $19.00 M(-89.1%) | $212.20 M(-8.4%) |
| June 2020 | - | $173.80 M(+898.9%) | $231.70 M(+258.7%) |
| Mar 2020 | - | $17.40 M(+770.0%) | $64.60 M(+15.6%) |
| Dec 2019 | $55.90 M | $2.00 M(-94.8%) | $55.90 M(-35.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | $38.50 M(+474.6%) | $86.20 M(+29.6%) |
| June 2019 | - | $6.70 M(-23.0%) | $66.50 M(-28.9%) |
| Mar 2019 | - | $8.70 M(-73.1%) | $93.50 M(-10.8%) |
| Dec 2018 | $104.80 M(+21.7%) | $32.30 M(+71.8%) | $104.80 M(+44.6%) |
| Sept 2018 | - | $18.80 M(-44.2%) | $72.50 M(+35.0%) |
| June 2018 | - | $33.70 M(+68.5%) | $53.70 M(+63.5%) |
| Mar 2018 | - | $20.00 M(+55.7%) | $32.85 M(-55.5%) |
| June 2017 | - | $12.85 M(-54.9%) | $73.81 M(-27.1%) |
| Mar 2017 | - | $28.52 M(+31.8%) | $101.21 M(+17.5%) |
| Dec 2016 | $86.13 M(+68.7%) | $21.64 M(+100.4%) | $86.13 M(+17.4%) |
| Sept 2016 | - | $10.80 M(-73.2%) | $73.35 M(-14.0%) |
| June 2016 | - | $40.25 M(+199.5%) | $85.29 M(+41.1%) |
| Mar 2016 | - | $13.44 M(+51.6%) | $60.43 M(+18.4%) |
| Dec 2015 | $51.04 M(+259.1%) | $8.87 M(-61.0%) | $51.04 M(+21.0%) |
| Sept 2015 | - | $22.74 M(+47.8%) | $42.18 M(+117.0%) |
| June 2015 | - | $15.39 M(+279.6%) | $19.44 M(+379.6%) |
| Mar 2015 | - | $4.05 M | $4.05 M |
| Dec 2014 | $14.21 M(-68.4%) | - | - |
| Dec 2013 | $44.93 M(+7.8%) | - | - |
| Dec 2012 | $41.68 M | - | - |
FAQ
- What is Surgery Partners annual free cash flow?
- What is the all time high annual FCF for Surgery Partners?
- What is Surgery Partners annual FCF year-on-year change?
- What is Surgery Partners quarterly free cash flow?
- What is the all time high quarterly FCF for Surgery Partners?
- What is Surgery Partners quarterly FCF year-on-year change?
- What is Surgery Partners TTM free cash flow?
- What is the all time high TTM FCF for Surgery Partners?
- What is Surgery Partners TTM FCF year-on-year change?
What is Surgery Partners annual free cash flow?
The current annual FCF of SGRY is $205.00 M
What is the all time high annual FCF for Surgery Partners?
Surgery Partners all-time high annual free cash flow is $205.00 M
What is Surgery Partners annual FCF year-on-year change?
Over the past year, SGRY annual free cash flow has changed by +$126.80 M (+162.15%)
What is Surgery Partners quarterly free cash flow?
The current quarterly FCF of SGRY is $45.00 M
What is the all time high quarterly FCF for Surgery Partners?
Surgery Partners all-time high quarterly free cash flow is $173.80 M
What is Surgery Partners quarterly FCF year-on-year change?
Over the past year, SGRY quarterly free cash flow has changed by -$10.90 M (-19.50%)
What is Surgery Partners TTM free cash flow?
The current TTM FCF of SGRY is $163.40 M
What is the all time high TTM FCF for Surgery Partners?
Surgery Partners all-time high TTM free cash flow is $231.70 M
What is Surgery Partners TTM FCF year-on-year change?
Over the past year, SGRY TTM free cash flow has changed by -$40.70 M (-19.94%)